Berliner Nanotechnology Company Doubles Turnover

Capsulution Continues to Build Trust among Customers and Investors

(PresseBox) ( Berlin, den, )
The Berlin Capsulution NanoScience AG completed the first half of 2006 by doubling the previous year’s turnover in the same period, while at the same time Capsulution’s EBIT increased to more than TEUR 200. Capsulution was able to enter a positive overall result in the ledger and is looking forward to an auspicious future. By the end of 2006 sales revenues of well over 1 million EUR are expected.

Alexander Hermann, chief financial officer, states: “We are pleased to have surpassed the goals we aspired to, for this generates a high degree of confidence in the company’s growth forecasts among all involved: customers, staff and investors. In the coming months the result will be impaired by high advance costs in the R & D area, especially due to scheduled pre-clinical experiments. However, the successful conclusion of these tests promises a considerable increase in turnover in the next fiscal year, as a large number of potential pharmaceutical customers hold them to be an important milestone for expanding and intensifying business relations with Capsulution.”
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to